NANOFH — Nanoform Finland Oyj Share News
0.000.00%
Last trade - 00:00- €63.63m
- €51.03m
- €3.55m
Brief: Nanoform, Celanese Expand Collaboration
Brief: Nanoform Finland Q2 Revenue Down At EUR 0.7 Million
Brief: Nanoform Collaborates With Takeda On Their Plasma-Derived Therapy Development
Brief: Nanoform Announces Its Intention To Carry Out A New Share Issue Of About 7 Mln New Shares
Brief: Nanoform Enters Exclusive Partnership With CBC
Brief: Nanoform, PlusVitech Partner To Repurpose Aprepitant As Treatment For Lung Cancer
Brief: Nanoform Finland Q4 EBITDA Loss Widens To EUR 5.4 Mln
Brief: Nanoform Wins Research And Development Grant Of EUR 4.3 Mln
Europe Research Roundup: Anglo American, Adevinta ASA, Auto Trader
Brief: Nanoformed Drug Candidate Receives FDA Orphan Drug Designation
Brief: Nanoform Q2 Oper Loss Stable At EUR 6.1 Mln
Brief: Nanoform Finland Informs Of Solid Balance Sheet
Brief: Nanoform Q1 Gross Margin at 78%
Brief: Nanoform Targets To Achieve More Non-GMP And GMP Projects In 2023
Brief: Nanoform Posts Q4 Gross Margin of 82% with Net Loss of EUR 5.6 Million
Nanoform Q3 EBIT Loss EUR 4.8 Million
Brief: Nanoform Finland Q2 EBITDA Loss Widens To EUR 5.5 Million
Brief: Nanoform Finland Partners With Pharmanovia
Brief: Nanoform Finland Q1 Loss Widens To EUR 5.3 Mln